Consultative hemostasis and thrombosis

Part 1: Hemorrhagic processes. Consultative process -- An approach to the bleeding patient: correlation of clinical symptoms and signs with laboratory testing -- Hemophilia A and B -- Less common congenital disorders of hemostasis -- Acquired coagulation disorders due to inhibitors -- von Willebrand disease -- General aspects of thrombocytopenia, platelet transfusions, and thrombopoietic growth factors -- Primary immune thrombocytopenia -- Congenital and acquired disorders of platelet function and number -- Purpura and other hematovascular disorders -- HHT -- Disseminated intravascular coagulation -- The cross-talk of inflammation and coagulation in infectious disease and their roles in disseminated intravascular coagulation -- Part 2: Thrombotic processes. Thrombophilia: clinical and laboratory assessment and management -- Pediatric aspects of thrombophilia -- Deep vein thrombosis, pulmonary embolism and primary pulmonary hypertension -- Venous thromboses at unusual sites -- The post thrombotic syndrome -- Thrombocytosis: essential thrombocytemia and reactive causes -- Antiphospholipid syndrome -- Antiplatelet treatment in cardiovascular medicine -- Non-arteriosclerotic arterial occlusive disease -- Thrombosis and cancer -- Thrombotic thrombocytopenic purpura -- Hemostatic disorders of complement activation (PNH and aHUS) -- Heparin-induced thrombocytopenia -- Part 3: Therapeutic agents. Antithrombotic agents -- Blood component and pharmacological agents -- Therapeutic apheresis: applications for hemorrhagic & thrombotic disorders -- Vena caval filters -- Part 4: Issues specific to women. Thrombotic risk of contraceptives and other hormonal therapies -- Bleeding and the management of hemorrhagic disorders in pregnancy -- Thrombophilia in pregnancy -- Part 5: Special issues. Surgery and hemostasis -- Anticoagulation in the perioperative period -- Understanding and managing the coagulopathy of liver disease -- Outpatient anticoagulant therapy -- Hematologic interventions for acute central nervous system disease -- Pending: atrial septal abnormalities and cryptogenic stroke -- Hemorrhage control and thrombosis following severe injury -- Hemostatic aspects of sickle cell disease"